CA
NZ
UK
AU
IND
US
● Based in Westport, Connecticut, Intensity Therapeutics is a clinical-stage biotechnology company developing intratumoral cancer therapies designed to kill tumours locally while triggering a systemic anti-tumour immune response.
The ticker IGRW (OTC:IGRW) is attached to a corporate name, Interactive Health Network, that hints at digital health or medical services. TheBusinessbehind the symbol is far more ordinary: it operates as House of Mohan, a distributor of incense, with shares changing hands at essentially …
ImageneBio, Inc. (NASDAQ: IMA) has quietly become one of the more intriguing names in inflammatory-disease drug development, backed by a well-capitalizedBalance Sheetand a lead antibody aimed at large dermatology markets. The stock, trading onNasdaqunder IMA, slipped modestly in recent action, but that small wobble …
The story behind ticker IMV (OTC:IMVIF)IF is less an active market opportunity than a cautionary corporate epilogue. IMV Inc., once a Nova Scotia-based clinical-stage immuno-oncology company, is no longer an operating business.
● Founded in 1980 and based in New Jersey, Integrated BioPharma manufactures and distributes vitamins, nutritional supplements and herbal products, largely through contractManufacturingfor distributors, marketers and healthcare providers.
Infinity Pharmaceuticals, Inc (OTC:INFIQ) once carried real ambition in cancer immunotherapy, and for years its shares traded actively onNasdaqunder INFI. Today the story reads very differently. The ticker now appears as INFIQ, the letter markets attach to companies in bankruptcy, and the stock changes …
● 6% single-session rally, but on a stock priced around a nickel that equates to a fraction of a cent, and no confirmed catalyst explains that specific move.
● MiNK Therapeutics is one of the smaller, more speculative names in cell therapy, and its stock behaves accordingly, capable of sharp swings on modest volume.
● Notably, the roughly 3% decline came even as Humacyte announced positive news, underscoring that the move had no clear negative catalyst and likely reflects thin, low-priced trading rather than a fundamental shift.
A sharp intraday slide has pushed Healthy Extracts Inc back onto the radar of speculative traders, even as the small nutraceutical company reports its fastest revenue growth in years. The move in HEALTHY EXTRACTS INC (OTCQB: HYEX) shares, flagged as a sharp drop on …
Please wait processing your request...